Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by thewolf4on Aug 13, 2019 1:04am
266 Views
Post# 30020719

SALP Unearned Interest

SALP Unearned InterestLots of shareholders seem to misunderstand this. SALP didn't convert any unearned interest on the debt to equity as part of the refinancing.

Assuming that the carrying value of the loans on the balance sheet is the amount that Prometic borrowed is incorrect.

The Q1 2019 balance sheet has debt of $146M. Between Q4 2013 and Q1 2019, Prometic borrowed roughly $210M from SALP. The reason for the difference is accounting adjustments that are made in accordance with IFRS. It doesn't change the total amount that was borrowed or the amount that's owed.

Interest that was legally earned prior to March 31, 2019 was added to the $210M borrowed to get the $229M that SALP converted.
Bullboard Posts